0001306830false00013068302024-11-042024-11-040001306830us-gaap:CommonStockMember2024-11-042024-11-040001306830ce:EURSeniorUnsecuredNotesDue2025Member2024-11-042024-11-040001306830ce:EURSeniorUnsecuredNotesDue2026Member2024-11-042024-11-040001306830ce:EURSeniorUnsecuredNotesDue2027Member2024-11-042024-11-040001306830ce:EURSeniorUnsecuredNotesDue2028Member2024-11-042024-11-040001306830ce:EURSeniorUnsecuredNotesDue2029Member2024-11-042024-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2024
CELANESE CORPORATION
(Exact name of registrant as specified in its charter)
| | | | | | | | | | | | | | |
| | | | |
| Delaware | | 001-32410 | | 98-0420726 |
| | | | | |
(State or other jurisdiction
of incorporation) | | (Commission File
Number) | | (IRS Employer
Identification No.) |
222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (972) 443-4000
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
| Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered |
| Common Stock, par value $0.0001 per share | CE | The New York Stock Exchange |
| 1.250% Senior Notes due 2025 | CE /25 | The New York Stock Exchange |
| 4.777% Senior Notes due 2026 | CE /26A | The New York Stock Exchange |
| 2.125% Senior Notes due 2027 | CE /27 | The New York Stock Exchange |
| 0.625% Senior Notes due 2028 | CE /28 | The New York Stock Exchange |
| 5.337% Senior Notes due 2029 | CE /29A | The New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure
On November 5, 2024, Lori J. Ryerkerk, Chair of the Board of Directors, Chief Executive Officer and President of Celanese Corporation (the "Company"), will make a presentation to investors and analysts via a webcast hosted by the Company at 11:00 a.m. ET (10:00 a.m. CT) regarding the Company's financial results for its third quarter 2024. The webcast, press release and prepared remarks from management may be accessed on our website at investors.celanese.com under News & Events / Events Calendar. A copy of the prepared remarks posted for the webcast is attached to this Current Report on Form 8-K ("Current Report") as Exhibit 99.1(a) and is incorporated herein solely for purposes of this Item 7.01 disclosure. During the webcast, management may make, and management's prepared remarks contain, references to certain Non-US GAAP financial measures. Non-US GAAP financial measures appearing in management's prepared remarks are defined and reconciled to the most comparable US GAAP financial measure in our Non-US GAAP Financial Measures and Supplemental Information document furnished with this Current Report as Exhibit 99.2 (and available on our website) and incorporated herein solely for purposes of this Item 7.01 disclosure.
Item 9.01 Financial Statements and Exhibits
(d) The following exhibits are being furnished herewith:
| | | | | | | | |
Exhibit
Number | | |
| Description |
| | |
| 99.1(a) | | |
| | |
| 99.2 | | |
| | |
| 104 | | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document contained in Exhibit 101) |
* In connection with the disclosure set forth in Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | | | | |
| | | | |
| | CELANESE CORPORATION |
| | By: | /s/ ASHLEY B. DUFFIE |
| | Name: | Ashley B. Duffie |
| | Title: | Senior Vice President, General Counsel and Corporate Secretary |
| | | | |
| Date: | November 4, 2024 | |
Exhibit 99.1(a)
Third Quarter 2024 Earnings Prepared Comments
Bill Cunningham, Celanese Corporation, Vice President, Investor Relations
This is the Celanese Corporation third quarter 2024 earnings prepared comments. The Celanese Corporation third quarter 2024 earnings release was distributed via Business Wire this afternoon and posted on our investor relations website, investors.celanese.com. As a reminder, some of the matters discussed below may include forward-looking statements concerning, for example, our future objectives and plans. Please note the cautionary language contained at the end of these comments. Also, some of the matters discussed include references to non-GAAP financial measures. Explanations of these measures and reconciliations to the comparable GAAP measures are included on our investor relations website under Financial Information/Non-GAAP Financial Measures. The earnings release and non-GAAP information and the reconciliations are being furnished to the SEC in a Current Report on Form 8-K. These prepared comments are also being furnished to the SEC in a separate Current Report on Form 8-K.
On the earnings conference call tomorrow morning, management will be available to answer questions.
Lori Ryerkerk, Celanese Corporation, Chair of the Board and Chief Executive Officer
Today we reported third quarter 2024 adjusted earnings of $2.44 per share (inclusive of approximately $0.30 per share of Mobility & Materials (M&M) transaction amortization1). Our results were impacted by broad deterioration of demand conditions in the quarter relative to our expectations which more than offset the improvements we continue to deliver from the implementation of value-enhancing initiatives like our M&M synergy projects and our Clear Lake acetic acid expansion. We delivered year-over-year expansion of adjusted EBIT, operating EBITDA, and operating EBITDA margins despite difficult conditions. However, the earnings growth generated from this execution fell short of our expectations. Delivery of our action plans could not offset the increasing headwinds caused by demand dynamics that worsened during the quarter, in some cases rapidly. Among the key drivers of the quarterly demand deterioration were:
•Automotive: An acute decline in Western Hemisphere automotive activity further strained demand challenges for Engineered Materials (EM). European Union auto registrations illustrate the severity and speed of the decline. Monthly registrations in the region climbed above one million for the
1 Calculated as intangible amortization from the M&M transaction divided by diluted weighted average shares outstanding.
second time this year in June, and then fell by approximately 45 percent in August. This caused an abrupt shift in demand patterns and a reduction in inventory levels across the auto value chain which were already at levels consistent with anticipated second half improvement.
•Industrial: Volumes into EM's industrial segments fell 8 percent sequentially, and declines were especially pronounced in Europe. Lower than anticipated sales into segments like stock shapes, rods, and sheets particularly affected volumes in the largest product lines like POM, GUR, and Nylon.
•Paints, coatings, and construction: Persistent anemic demand conditions across these segments continue to contribute to a demand environment for the Acetyl Chain (AC) that is uneven and, in some countries, continuing to contract. Additional vinyl acetate monomer (VAM) supply that came online further outpaced demand and amplified continued weakness in construction and solar panels which caused margin compression in the vinyl chain2 in Asia.
While the macroeconomic challenges we are facing are not unique to Celanese, we remain committed to identifying additional ways to improve our performance. We continue to accelerate our controllable action plans, and the steps we are taking are showing up in our results:
•Within AC, the agility from our consistent investments to advance optionality enabled the business to continue to pivot toward available demand and once again deliver operating EBITDA margins above 25 percent for 30 consecutive quarters.
•Within EM, substantial delivery of synergies from projects like manufacturing footprint optimization, functional cost take-out, and realization of growth programs from the project pipeline model partially offset the impact of demand declines. Overall, the synergy projects associated with the integration remain on track.
Unfortunately, when you look at the big picture, the impact of these controllable actions has been increasingly offset by headwinds throughout the year, and the outlook across the majority of our end-markets is poor for the remainder of 2024 and uncertain going into 2025. The soft demand environment is impacting our cash generation due to lower earnings and slower cycling of working capital, including an unanticipated inventory build due to a rapid downturn in our order book in end-markets like auto. Given our 2024 results thus far and our expectation of continued demand challenges, we are continuing to take bold actions to strengthen earnings and cash generation. These actions include the following:
2 The vinyl chain includes VAM, emulsions, redispersible powders (RDP), and ethylene vinyl acetate (EVA).
•We are implementing cost reduction programs that are expected to realize greater than $75 million by the end of 2025. These reductions are incremental to what we have achieved through the synergy projects that have already been completed or initiated. The focus is on driving selling, general, and administrative (SG&A) productivity to better align our cost structure with current market realities, while maintaining the ability to scale when recovery begins and growth resumes.
•We intend to temporarily reduce our quarterly dividend by approximately 95 percent beginning in the first quarter of 2025. We recognize the importance of the dividend to our shareholders and have a track record of annual growth in the dividends paid per share for over a decade. Given the challenging business backdrop that I described, the pace of our deleveraging has been below our expectations. Therefore, we have recently reassessed a variety of options to support our deleveraging and determined, with the support of the Board, that a reduction in the dividend is the most prudent and cost-effective path forward. Our intent is for this to be a temporary measure during this deleveraging phase.
•We are reducing our production to match current demand. This includes temporarily idling facilities in every region to save fixed costs and drive inventory reductions across the global network. We anticipate these actions will generate an approximately $200 million EM sequential inventory release in the fourth quarter.
•We continue to be relentlessly focused on efficiently and stringently deploying capital, and will target next year’s capex spending to be approximately $400 million.
•We secured a new 364-day delayed draw term loan with availability up to $1 billion that we plan to put toward our debt maturities in the first quarter of 2025. This new term loan will allow us to cost-effectively bridge timing impacts of our cash generation due to poor demand.
While these actions may take some time to fully pull through to our financial results, we want to be clear on the path forward. Our long history of operational excellence, strong execution, and focus on controllable actions positions us well to navigate a wide range of environments. The Clear Lake acetic acid expansion will not only drive near term productivity, but also provides low cost available capacity to capture meaningful growth as demand recovers. The actions we have taken in EM and at the corporate level have lowered our fixed cost base. As we ramp up our growth trajectory through the project pipeline in EM, that lower fixed cost base will amplify the margin of every incremental ton sold. When recovery does take hold, we are confident these transformational steps should generate long-term growth and value creation.
With that, let me turn it over to Scott and Chuck to further discuss our third quarter business and financial performance.
Scott Richardson, Celanese Corporation, Executive Vice President and Chief Operating Officer
In the third quarter, Engineered Materials (EM) delivered quarterly adjusted EBIT of $237 million and operating EBITDA of $348 million at margins of 16 and 23 percent, respectively. The adjusted EBIT contribution for the quarter was impacted by a demand environment that remained constrained and, as Lori described in the case of auto, rapidly degraded relative to our expectations. We delivered a 3 percent year-over-year increase in adjusted EBIT while sales fell by 3 percent over the same period. When removing the impact of the divested Food Ingredients business, the year-over-year increase in adjusted EBIT was 8 percent3 while sales fell by 1 percent. Contributing to the sales decline, EM has continued to face an unfavorable pricing environment due to intensifying competitive dynamics in standard grade applications that are offsetting improvements in costs. Through execution against controllable actions like commercial integration, manufacturing footprint optimization, and functional cost synergies, EM was able to deliver slightly improved adjusted EBIT while laying transformational building blocks that will drive value in the future.
Even so, the third quarter adjusted EBIT result fell short of our expectations and was 12 percent below the lower end of our targeted range. As we anticipated, the quarter was impacted by an approximate $30 million cost from drawing inventory mainly associated with production campaign timing. However, the moderate sequential volume expansion we expected across most products and applications did not develop. Instead, volumes fell by 2 percent sequentially due to unexpected shifts in demand. These volumetric declines were offset by mix improvement from higher margin products like Vamac® and Hytrel®.
The largest impact to the business for the quarter was from the automotive sector, especially in the Western Hemisphere where EM's content per vehicle is typically higher. Auto in Europe and North America experienced a shock to the demand patterns that had been relatively steady for the previous several quarters, with swift sales declines in both regions that led to a pullback in auto builds. In Europe, third party forecasts called for a 3 percent third quarter year-over-year increase in auto builds as recently as this past July. Just three months later, the actual builds were recorded as having a quarterly decrease of
3 The Food Ingredients (FI) business was divested and contributed to the Nutrinova Food Ingredients joint venture (FI JV) on September 27, 2023. Q3 2023 EM adjusted EBIT included adjusted EBIT of $13 million related to FI, Q3 2023 EM Net sales included $36 million related to FI and Q3 2024 EM adjusted EBIT included $3 million of equity earnings related to FI JV.
2.5 percent. Our anticipation of a moderate sequential second half increase in auto did not materialize. Auto builds at the global level were down slightly sequentially in the third quarter and were down 14 percent in Europe. Likewise, North American auto builds fell by 6 percent sequentially. Decreases of this nature move quickly through the value chain in a bull whip manner, abruptly impacting volumes and inventory levels in the Western Hemisphere and causing us to lag auto builds. In Asia, demand remained sluggish but did not display the same trajectory as the Western Hemisphere. Here, EM’s year-over-year volumes were mainly flat to the previous year and outperformed auto builds.
The headwinds from automotive also affected the overall nylon business, which saw margin compression even as the commercial teams were able to keep volumes consistent with the second quarter. Indices in all regions reported price declines throughout the quarter. China prices for undifferentiated nylon polymer remained challenged and reflect supply that is outpacing sluggish demand. Our focus remains on our differentiated compounded products, and we now have the flexibility to swiftly adjust to polymer price fluctuations by choosing to either produce or externally source. This more contemporary nylon business model continues to provide needed flexibility in our manufacturing and sourcing decisions. Consistent with last quarter, we are strategically sourcing more standard nylon 6,6 polymer grades to take advantage of local conditions, while importing our differentiated compounded grades.
Faced with severe external headwinds, we are focusing our attention on controllable actions. We have completed or initiated all of our synergy plans for 2024. The continued scaling of our project pipeline model partially offsets near-term headwinds, while also building the foundation for future growth. Although near-term end-market dynamics are likely to remain uneven and unpredictable, our customers desire innovation and we are continually taking proactive steps to deliver value in response to those needs. The value per customer project won has increased by nearly 30 percent compared to 2022, and is an indication of the progress of the commercial integration. Our closed - won metric, which measures the total value of awarded commercial projects, increased 18 percent year-over-year for electric vehicle projects. The depressed demand environment has slowed the ramp up of project revenues. The work being done now in the project pipeline positions us for growth as demand recovers, and earnings will be amplified by the cost transformations we have made through our manufacturing footprint and sourcing strategy.
In the fourth quarter, we expect further demand declines and additional one-time challenges that will impact adjusted EBIT. We anticipate a headwind of approximately $40 million related to severe but temporary destocking in automotive, industrial, and with our distribution customers, as well as approximately $15 million from sequential seasonal declines associated with product mix. We also
anticipate a reduction in affiliate earnings of approximately $15 million. Finally, we expect a headwind of approximately $15 million associated with temporarily idling production to better align with demand in the fourth quarter, enabling working capital improvement through inventory draw down. We anticipate the scope of the production reductions will be broad and include ten sites across the EM global network. While the production curtailments are acute, we anticipate they will be short term and we are targeting to generate $200 million in working capital improvement through inventory release. Given these inputs, we anticipate fourth quarter adjusted EBIT of $130 to $150 million.
The unusual pressures on demand in the fourth quarter, while intense, are mainly driven by non-recurring dynamics. We expect fourth quarter destocking in auto and industrial to be seasonal in nature, and as it eases we will realign our production to this demand cadence. We will continue to drive our synergy projects that are expected to further lower our cost position, which could have pricing compression offsets depending on the demand environment.
The Acetyl Chain (AC) delivered third quarter adjusted EBIT of $276 million and operating EBITDA of $339 million, at margins of 23 and 28 percent, respectively. Net sales in the quarter decreased sequentially by 1 percent, comprised of a 2 percent decline in price, partially offset by currency favorability. Volumes were flat sequentially with the team flexing incremental opportunistic volumes in downstream derivatives such as acetate tow which offset volume declines across the balance of the chain. The team delivered these results despite lingering financial impacts from the second quarter force majeure and production impacts, a persistently stagnant demand environment, and unfavorable supply and demand dynamics in Asia, particularly for VAM.
The third quarter was characterized globally by continued lackluster demand in key end-markets like paints, coatings, and construction. However, supply dynamics are distinctly different between the two geographical regions.
In the Western Hemisphere, the team was able to successfully mitigate the third quarter financial impact from the previous quarter’s force majeure and other operational issues in line with our previous guidance of $5 to $10 million. These financial headwinds included sourcing higher cost material from co-producers, shifting production to higher cost assets, and lost sales volume primarily in Europe. The financial impact would have been far greater without the productivity gains we achieved from our new acetic acid expansion at Clear Lake. The team was able to flex our network and ramp up production rates at Clear Lake to help rebuild our depleted inventory, allowing us to capture approximately $20 million of contributions from the acetic acid expansion. I want to specifically thank our manufacturing, supply chain,
and procurement teams for all their work, which culminated in a new quarterly production record for acetic acid at Clear Lake.
Our primary challenge in the Western Hemisphere has been soft demand for paints, coatings, and construction, particularly in Europe. Supply to the West has also decreased as imports from Asia to Europe are below historical trends due to production, shipping, and infrastructure costs along with other logistical complexities for the majority of Asian producers.
In Asia there has been new capacity added this year in both acetic acid and VAM. However, the incremental financial headwinds we are seeing in the third quarter are primarily related to VAM. In the case of acetic acid, we are not anticipating significant incremental impacts as a result of the capacity that has been added or the additional near-term capacity. The region has already largely been operating at or near the cost curve and our Asia acetic acid variable margin contribution has been relatively consistent since the third quarter of 2022, with the exception being the third quarter of 2023 as a result of a series of planned and unplanned outages. Demand in Asia has steadily grown but at rates inadequate to absorb the new capacity and much lower than would be expected compared to overall GDP, primarily due to the weakness in the China construction sector.
For VAM, in the third quarter we had anticipated a sequential lift in pricing based on the upward trend we saw in acetic acid in July driven by the heavier turnaround season in Asia. Allowing for a normal time lag, we had anticipated this momentum to flow through our integrated value chain. Instead, acid pricing deteriorated from the peak in mid-August and the brief acid inflection did not translate to VAM. In fact, average VAM pricing across the third quarter sequentially declined between $75 to $100 per ton in Asia.
The decline in pricing was driven by soft demand coupled with new VAM capacity that achieved on-specification production within the third quarter. This was the third VAM capacity addition in 2024 to come on line in a demand environment being driven by weakness in construction applications and EVA, primarily due to excess inventory in solar panels. The combination of weak demand and supply overhang has rippled down the chain, and variable margin contributions from the Asia vinyl chain were the lowest we have seen since the fourth quarter of 2015. Based on the increased optionality and enhanced flexibility, our third quarter adjusted EBIT was approximately 45 percent higher than the fourth quarter of 2015, which was $191 million4.
In the fourth quarter, though demand in the Western Hemisphere was already weak, we are seeing additional softness that is typical of year-end seasonality and destocking. Historically in Asia, seasonal
4 Fourth quarter 2015 adjusted EBIT is inclusive of Acetyl Chain and Consumer Specialties. Consumer Specialties included Acetate Tow and Food Ingredients.
fourth quarter demand ahead of Chinese New Year partially offsets seasonality in the West. Unfortunately, in Asia we have not seen any indications of incremental demand in anticipation of the first quarter or as a result of the China stimulus. Globally for AC, we expect modest sequential declines in both price and volume. In this environment we are proactively taking steps to align our supply with customer demand. To that end, we have flexed our network to optimize cost and have temporarily idled production at our Singapore acetic acid, VAM, Esters, and VAE production units in the first half of the fourth quarter. Additionally, we are idling our Frankfurt VAM plant and plan to continue to use it as our swing capacity to meet demand. Inclusive of these dynamics we anticipate fourth quarter adjusted EBIT of $250 to $265 million.
Though the environment is challenging, the hallmark of our AC team is agility and optionality. The team has built a track record over the last half decade of decisively pivoting and capturing incremental value when we see opportunity. Unfortunately, in the current macroeconomic climate, opportunities are scarce. Given the current supply and demand environment, we believe the 2024 earnings run rate is representative of our near-term expectations for AC.
Chuck Kyrish, Celanese Corporation, Senior Vice President and Chief Financial Officer
I want to provide additional context for our Other Activities results before going into free cash flow performance and our actions to drive deleveraging.
In the third quarter we reported a net expense of $56 million in Other Activities adjusted EBIT, a sequential expense reduction of $35 million, which was favorable versus our forecast due to some non-cash costs reductions that are not expected to repeat. For the fourth quarter we anticipate the adjusted EBIT net expense to be in line with our previous guidance of approximately $80 million. Inclusive of fourth quarter guidance this would translate to approximately a 10 percent reduction in net expenses for the year in comparison to 2023. The reduction is a culmination of our team’s exhaustive efforts related to SAP and systems integration and numerous other synergy capture initiatives. We anticipate 2025 will reflect a full year of synergy benefits from projects implemented in 2024 along with a portion of the additional cost reduction initiatives Lori outlined that should be completed in 2025.
Turning to cash generation, for the third quarter we reported free cash flow of $(16) million. Performance for the quarter was below expectations due to lower earnings and unfavorable working capital. While we had anticipated working capital to be a small source of cash, we ended the quarter with working capital as
a $238 million use of cash. This headwind was partially driven by production that anticipated sequentially higher demand, while demand ultimately fell short of our expectations and resulted in a near term unfavorable impact to working capital.
For the fourth quarter, we are expecting a sequential lift in free cash flow of approximately $400 million as a result of favorable working capital reduction efforts and roughly $100 million lower cash interest expense, due to timing of bond coupon payments that are more concentrated in the first and third quarters. There is a timing component to the inventory draw and some of the benefits could shift between the fourth quarter and the first quarter of 2025.
There are a number of non-repeating factors in 2024 that drove free cash flow unusually low for this level of earnings. Let me walk through the impact of each in turn.
•Cash taxes are elevated by approximately $150 million largely driven by transfer tax payments related to restructuring, which we anticipate recouping in the coming years through corresponding foreign tax credits, as well as the timing of income versus tax payments across 2024 which vary on a year-to-year basis.
•In 2024, we are anticipating working capital to be an approximate $150 million use of cash versus our previous expectation of being a source of cash.
•This year’s M&M cash cost to achieve synergies is expected to land near the middle of our previous guidance of $100 to $150 million. We anticipate 2024 cost to represent a peak as some of the largest cost are a result of SAP integration, functional cost reductions, and the previously announced manufacturing footprint optimization with the majority of these cost being incurred in 2024 and early 2025.
For comparison, in a year without these challenges, using our full year 2024 operating EBITDA outlook and limiting capital expenditures to approximately $400 million, we would expect to generate free cash flows between $800 to $900 million. Therefore, even without visibility to earnings improvement next year, we can expect an increase in free cash flow.
We continue to progress our deleveraging efforts and have retired $1 billion in bonds this year. In the third quarter we repaid an approximately $500 million bond maturity, with a portion of this payment being temporarily placed on the revolver. At the end of the quarter our U.S. revolver balance was $120 million, primarily resulting from the unanticipated working capital build. We intend to repay this balance and have our $1.75 billion U.S. revolver undrawn at year end.
In the first quarter we have $1.3 billion in bonds maturing. We expect cash flow timing impacts from the drop in demand, unwinding the working capital build, and higher cash cost to achieve synergies in the next six months. Therefore, as you saw in the 8-K that was released today, we have procured a delayed draw term loan for up to $1 billion as a cost effective bridge. This provides incremental flexibility with discretion on timing to draw against the loan and the amount borrowed. The loan will be prepayable without penalty and will begin accruing interest after the loan has been drawn. We expect to draw on the term loan in the first quarter of 2025 and use the proceeds toward the $1.3 billion maturing debt.
In addition to the cash flow timing, the earnings headwinds also warranted a proactive look at our debt covenants, so we revised the covenants given the benefits of the Food Ingredients divestiture rolled off in the third quarter.
Our priority is unchanged – we are focused on deleveraging to our targeted leverage ratio of 3x net debt to EBITDA as rapidly as possible while creating long-term value for our investors. As Lori discussed, based on the persistently lower demand environment and its impact on earnings, we intend to reduce our quarterly dividend by approximately 95 percent beginning in the first quarter of 2025. We believe it is prudent and in the best interest of delivering long-term value to reduce the dividend and deploy this cash to debt repayment. In reaching this decision, we assessed many options to support our deleveraging efforts. This was not a decision taken lightly as we recognize the importance of the dividend to our shareholders. Ultimately, we concluded this is one of the most cost-effective sources of capital and accelerates our deleveraging timing. The cash we will divert from dividends to repay debt will consequently be available in future years for shareholder value creation in the form of dividends and share repurchases once we return to a balanced capital allocation strategy.
Additionally, we continue to evaluate divestiture opportunities. As previously discussed, some are comparable in scale to our recent Food Ingredients transaction. Although current conditions make timing somewhat uncertain, we are actively assessing the available options. The future cash flow generation capability of Celanese is significant and we look forward to accelerating the return of capital to shareholders once we have progressed in our deleveraging efforts.
Lori Ryerkerk, Celanese Corporation, Chair of the Board and Chief Executive Officer
In the fourth quarter, we expect destocking across key end-markets as well as earnings impacts from slowing our production to align with those demand levels. Given these conditions, we anticipate fourth quarter adjusted earnings per share of approximately $1.25. While we have not fully developed our outlook for 2025, there is currently little indication of a near-term return to normalized demand patterns or supply and demand balances.
At Celanese, we hold ourselves to a high standard, and our third quarter results and near-term outlook do not meet our expectations. Given the challenging industry headwinds that have negatively impacted the performance of our business, we are focusing on additional actions to strengthen the company and create value through business improvement, earnings growth, free cash flow expansion, and deleveraging. I am confident that our actions position Celanese for long-term success and shareholder value creation.
Forward-Looking Statements
These prepared comments may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, deleveraging efforts, dividend policy, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in these comments. These risks and uncertainties include, among other things: changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw materials prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; the possibility that we will not be able to realize the anticipated benefits of the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc. (the "M&M Acquisition"), including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities; impairments of goodwill or intangible assets; increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies; risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all; risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility; the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; increased price competition and the introduction of competing products by other companies; the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with the Company's strategy; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or the Israel-Hamas conflict) or terrorist incidents or as a result of weather, natural disasters, or other crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, anti-dumping and countervailing duties, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters; potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry, and the success of our deleveraging efforts; changes in currency exchange rates and interest rates; tax rates and changes thereto; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.
Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
Non-GAAP Financial Measures
These prepared comments, and statements made in connection with these prepared comments, refer to non-GAAP financial measures. For more information on the non-GAAP financial measures used by the Company, including the most directly comparable GAAP financial measure for each non-GAAP financial measure used, including definitions and reconciliations of the differences between such non-GAAP financial measures and the comparable GAAP financial measures, please refer to the Non-US GAAP Financial Measures and Supplemental Information document available on our website, investors.celanese.com, under Financial Information/Financial Document Library.
Non-US GAAP Financial Measures and Supplemental Information
November 4, 2024
In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.
Purpose
The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarterly.
Presentation
This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.
Use of Non-US GAAP Financial Measures
From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.
Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.
Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.
This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.
Specific Measures Used
This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt
is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation shareholders' equity.
Definitions
•Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8). We believe that adjusted EBIT provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for planning and budgeting, monitoring and evaluating financial and operating results and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales. Adjusted EBIT margin has the same uses and limitations as Adjusted EBIT. •Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We believe that Operating EBITDA provides transparent and useful information to investors, analysts and other parties in evaluating our operating performance relative to our peer companies. Operating EBITDA margin is defined by the Company as Operating EBITDA divided by net sales. Operating EBITDA margin has the same uses and limitations as Operating EBITDA.
•Operating profit (loss) attributable to Celanese Corporation is defined by the Company as operating profit (loss), less earnings (loss) attributable to noncontrolling interests ("NCI"). We believe that operating profit (loss) attributable to Celanese Corporation provides transparent and useful information to management, investors, analysts and other parties in evaluating our core operational performance. Operating margin attributable to Celanese Corporation is defined by the Company as operating profit (loss) attributable to Celanese Corporation divided by net sales. Operating margin attributable to Celanese Corporation has the same uses and limitations as Operating profit (loss) attributable to Celanese Corporation.
•Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We believe that adjusted earnings per share provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of the above stated items that affect comparability and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
•Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures. We believe that free cash flow provides useful information to management, investors, analysts and other parties in evaluating the Company's liquidity and credit quality assessment because it provides an indication of the long-term cash generating ability of our business. Although we use free cash flow as a measure to assess the liquidity generated by our business, the use of free cash flow has important limitations, including that free cash flow does not reflect the cash requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and postretirement funding obligations. Free cash flow is not a measure of cash available for discretionary expenditures since the Company has certain debt service and finance lease payments that are not deducted from that measure. We do not provide reconciliations for free cash flow on a forward-looking basis when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of items such as working capital changes, fluctuations in foreign currency exchange rates, the impact and timing of potential acquisitions and divestitures, and other structural changes, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
•Net debt is defined by the Company as total debt less cash and cash equivalents. We believe that net debt provides useful information to management, investors, analysts and other parties in evaluating changes to the Company's capital structure and credit quality assessment.
•Return on invested capital (adjusted) is defined by the Company as adjusted EBIT, tax effected using the adjusted tax rate, divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation shareholders' equity. We believe that return on invested capital (adjusted) provides useful information to management, investors, analysts and other parties in order to assess our income generation from the point of view of our shareholders and creditors who provide us with capital in the form of equity and debt and whether capital invested in the Company yields competitive returns.
Supplemental Information
Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:
•Net sales for each of our business segments and the percentage increase or decrease in net sales attributable to price, volume, currency and other factors for each of our business segments.
•Cash dividends received from our equity investments.
•For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as NCI. Amounts referred to as "attributable to Celanese Corporation" are net of any applicable NCI.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
Table 1
Celanese Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 |
| | | | | (In $ millions) |
| Net earnings (loss) attributable to Celanese Corporation | | | | | 116 | | | 155 | | | 121 | | | 1,960 | | | 698 | | | 951 | | | 220 | | | 91 | |
| (Earnings) loss from discontinued operations | | | | | 2 | | | 1 | | | — | | | 9 | | | 6 | | | 1 | | | (1) | | | 3 | |
| Interest income | | | | | (5) | | | (10) | | | (13) | | | (39) | | | (12) | | | (12) | | | (7) | | | (8) | |
| Interest expense | | | | | 169 | | | 174 | | | 169 | | | 720 | | | 178 | | | 178 | | | 182 | | | 182 | |
| Refinancing expense | | | | | — | | | — | | | — | | | 7 | | | — | | | 7 | | | — | | | — | |
| Income tax provision (benefit) | | | | | 61 | | | 29 | | | 33 | | | (790) | | | (575) | | | (236) | | | (4) | | | 25 | |
Certain Items attributable to Celanese Corporation (Table 8) | | | | | 114 | | | 102 | | | 97 | | | (114) | | | 139 | | | (438) | | | 54 | | | 131 | |
| Adjusted EBIT | | | | | 457 | | | 451 | | | 407 | | | 1,753 | | | 434 | | | 451 | | | 444 | | | 424 | |
Depreciation and amortization expense(1) | | | | | 187 | | | 181 | | | 176 | | | 691 | | | 174 | | | 173 | | | 172 | | | 172 | |
| Operating EBITDA | | | | | 644 | | | 632 | | | 583 | | | 2,444 | | | 608 | | | 624 | | | 616 | | | 596 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 |
| | | | | (In $ millions) |
| Engineered Materials | | | | | 16 | | | 11 | | | 45 | | | 15 | | | 15 | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Other Activities(2) | | | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
| Accelerated depreciation and amortization expense | | | | | 16 | | | 11 | | | 45 | | | 15 | | | 15 | | | — | | | — | | | — | |
Depreciation and amortization expense(1) | | | | | 187 | | | 181 | | | 176 | | | 691 | | | 174 | | | 173 | | | 172 | | | 172 | |
| Total depreciation and amortization expense | | | | | 203 | | | 192 | | | 221 | | | 706 | | | 189 | | | 173 | | | 172 | | | 172 | |
______________________________
(1)Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above.
(2)Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
| | | | | | | | |
| Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 |
| | | | | | | | | (In $ millions, except percentages) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Operating Profit (Loss) / Operating Margin | | | | | | | | | | | | | | | | | | | | |
| Engineered Materials | | | | | | | | | 102 | | | 6.9 | % | | 138 | | | 9.4 | % | | 89 | | | 6.5 | % | | 1,083 | | | 17.6 | % | | 122 | | | 8.7 | % | | 691 | | | 45.2 | % | | 158 | | | 10.0 | % | | 112 | | | 6.9 | % |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | | | | | 239 | | | 20.1 | % | | 242 | | | 20.1 | % | | 254 | | | 20.1 | % | | 1,109 | | | 22.7 | % | | 264 | | | 22.4 | % | | 272 | | | 22.3 | % | | 295 | | | 23.9 | % | | 278 | | | 22.2 | % |
Other Activities(1) | | | | | | | | | (93) | | | | | (130) | | | | | (133) | | | | | (505) | | | | | (127) | | | | | (121) | | | | | (118) | | | | | (139) | | | |
| Total | | | | | | | | | 248 | | | 9.4 | % | | 250 | | | 9.4 | % | | 210 | | | 8.0 | % | | 1,687 | | | 15.4 | % | | 259 | | | 10.1 | % | | 842 | | | 30.9 | % | | 335 | | | 12.0 | % | | 251 | | | 8.8 | % |
| Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials | | | | | | | | | 2 | | | | | (4) | | | | | (1) | | | | | (3) | | | | | 1 | | | | | (2) | | | | | (2) | | | | | — | | | |
| Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain | | | | | | | | | 2 | | | | | 2 | | | | | 4 | | | | | 7 | | | | | 2 | | | | | — | | | | | 3 | | | | | 2 | | | |
| Operating Profit (Loss) Attributable to Celanese Corporation | | | | | | | | | 244 | | | 9.2 | % | | 252 | | | 9.5 | % | | 207 | | | 7.9 | % | | 1,683 | | | 15.4 | % | | 256 | | | 10.0 | % | | 844 | | | 31.0 | % | | 334 | | | 11.9 | % | | 249 | | | 8.7 | % |
| Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation | | | | | | | | | | | | | | | | | | | | |
| Engineered Materials | | | | | | | | | 100 | | | 6.8 | % | | 142 | | | 9.7 | % | | 90 | | | 6.5 | % | | 1,086 | | | 17.7 | % | | 121 | | | 8.6 | % | | 693 | | | 45.4 | % | | 160 | | | 10.1 | % | | 112 | | | 6.9 | % |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | | | | | 237 | | | 19.9 | % | | 240 | | | 20.0 | % | | 250 | | | 19.8 | % | | 1,102 | | | 22.6 | % | | 262 | | | 22.2 | % | | 272 | | | 22.3 | % | | 292 | | | 23.7 | % | | 276 | | | 22.1 | % |
Other Activities(1) | | | | | | | | | (93) | | | | | (130) | | | | | (133) | | | | | (505) | | | | | (127) | | | | | (121) | | | | | (118) | | | | | (139) | | | |
| Total | | | | | | | | | 244 | | | 9.2 | % | | 252 | | | 9.5 | % | | 207 | | | 7.9 | % | | 1,683 | | | 15.4 | % | | 256 | | | 10.0 | % | | 844 | | | 31.0 | % | | 334 | | | 11.9 | % | | 249 | | | 8.7 | % |
| Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation | | | | | | | | | | | | | | | | | | | | |
| Engineered Materials | | | | | | | | | 46 | | | | | 49 | | | | | 50 | | | | | 87 | | | | | 45 | | | | | 12 | | | | | 20 | | | | | 10 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | | | | | 34 | | | | | 33 | | | | | 36 | | | | | 132 | | | | | 33 | | | | | 33 | | | | | 32 | | | | | 34 | | | |
Other Activities(1) | | | | | | | | | 16 | | | | | 13 | | | | | 15 | | | | | 34 | | | | | 28 | | | | | 1 | | | | | 6 | | | | | (1) | | | |
| Total | | | | | | | | | 96 | | | | | 95 | | | | | 101 | | | | | 253 | | | | | 106 | | | | | 46 | | | | | 58 | | | | | 43 | | | |
| Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation | | | | | | | | | | | | | | | | | | | | |
| Engineered Materials | | | | | | | | | — | | | | | — | | | | | — | | | | | (1) | | | | | (1) | | | | | — | | | | | — | | | | | — | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | |
Other Activities(1) | | | | | | | | | 3 | | | | | 2 | | | | | 2 | | | | | (68) | | | | | (66) | | | | | (1) | | | | | (2) | | | | | 1 | | | |
| Total | | | | | | | | | 3 | | | | | 2 | | | | | 2 | | | | | (69) | | | | | (67) | | | | | (1) | | | | | (2) | | | | | 1 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Certain Items Attributable to Celanese Corporation (Table 8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Engineered Materials | | | | | | | | | 91 | | | | | 74 | | | | | 61 | | | | | (324) | | | | | 34 | | | | | (476) | | | | | 25 | | | | | 93 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | | | | | 5 | | | | | 4 | | | | | 10 | | | | | 24 | | | | | 5 | | | | | 5 | | | | | 8 | | | | | 6 | | | |
Other Activities(1) | | | | | | | | | 18 | | | | | 24 | | | | | 26 | | | | | 186 | | | | | 100 | | | | | 33 | | | | | 21 | | | | | 32 | | | |
| Total | | | | | | | | | 114 | | | | | 102 | | | | | 97 | | | | | (114) | | | | | 139 | | | | | (438) | | | | | 54 | | | | | 131 | | | |
Adjusted EBIT / Adjusted EBIT Margin | | | | | | | | | | | | | | | | | | | | |
| Engineered Materials | | | | | | | | | 237 | | | 16.0 | % | | 265 | | | 18.1 | % | | 201 | | | 14.6 | % | | 848 | | | 13.8 | % | | 199 | | | 14.2 | % | | 229 | | | 15.0 | % | | 205 | | | 12.9 | % | | 215 | | | 13.2 | % |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | | | | | 276 | | | 23.2 | % | | 277 | | | 23.0 | % | | 296 | | | 23.5 | % | | 1,258 | | | 25.8 | % | | 300 | | | 25.4 | % | | 310 | | | 25.4 | % | | 332 | | | 26.9 | % | | 316 | | | 25.3 | % |
Other Activities(1) | | | | | | | | | (56) | | | | | (91) | | | | | (90) | | | | | (353) | | | | | (65) | | | | | (88) | | | | | (93) | | | | | (107) | | | |
| Total | | | | | | | | | 457 | | | 17.3 | % | | 451 | | | 17.0 | % | | 407 | | | 15.6 | % | | 1,753 | | | 16.0 | % | | 434 | | | 16.9 | % | | 451 | | | 16.6 | % | | 444 | | | 15.9 | % | | 424 | | | 14.9 | % |
___________________________
(1)Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
| | | | | | | | |
| Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.) | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 |
| | | | | | | | | (In $ millions, except percentages) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Depreciation and Amortization Expense(1) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Engineered Materials | | | | | | | | | 111 | | | | | 110 | | | | | 102 | | | | | 447 | | | | | 112 | | | | | 111 | | | | | 112 | | | | | 112 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | | | | | 63 | | | | | 61 | | | | | 57 | | | | | 217 | | | | | 54 | | | | | 55 | | | | | 54 | | | | | 54 | | | |
Other Activities(2) | | | | | | | | | 13 | | | | | 10 | | | | | 17 | | | | | 27 | | | | | 8 | | | | | 7 | | | | | 6 | | | | | 6 | | | |
| Total | | | | | | | | | 187 | | | | | 181 | | | | | 176 | | | | | 691 | | | | | 174 | | | | | 173 | | | | | 172 | | | | | 172 | | | |
Operating EBITDA / Operating EBITDA Margin | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Engineered Materials | | | | | | | | | 348 | | | 23.5 | % | | 375 | | | 25.6 | % | | 303 | | | 22.0 | % | | 1,295 | | | 21.1 | % | | 311 | | | 22.1 | % | | 340 | | | 22.3 | % | | 317 | | | 20.0 | % | | 327 | | | 20.1 | % |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | | | | | 339 | | | 28.5 | % | | 338 | | | 28.1 | % | | 353 | | | 28.0 | % | | 1,475 | | | 30.2 | % | | 354 | | | 30.0 | % | | 365 | | | 29.9 | % | | 386 | | | 31.3 | % | | 370 | | | 29.6 | % |
Other Activities(2) | | | | | | | | | (43) | | | | | (81) | | | | | (73) | | | | | (326) | | | | | (57) | | | | | (81) | | | | | (87) | | | | | (101) | | | |
| Total | | | | | | | | | 644 | | | 24.3 | % | | 632 | | | 23.8 | % | | 583 | | | 22.3 | % | | 2,444 | | | 22.3 | % | | 608 | | | 23.7 | % | | 624 | | | 22.9 | % | | 616 | | | 22.0 | % | | 596 | | | 20.9 | % |
___________________________
(1)Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details. (2)Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
Table 3
Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 | |
| | | | | | | | | | | per share | | | | per share | | | | per share | | | | per share | | | | per share | | | | per share | | | | per share | | | | per share | |
| | | | | | | | | (In $ millions, except per share data) | |
| Earnings (loss) from continuing operations attributable to Celanese Corporation | | | | | | | | | 118 | | | 1.08 | | | 156 | | | 1.42 | | | 121 | | | 1.10 | | | 1,969 | | | 18.00 | | | 704 | | | 6.43 | | | 952 | | | 8.70 | | | 219 | | | 2.00 | | | 94 | | | 0.86 | | |
| Income tax provision (benefit) | | | | | | | | | 61 | | | | | 29 | | | | | 33 | | | | | (790) | | | | | (575) | | | | | (236) | | | | | (4) | | | | | 25 | | | | |
| Earnings (loss) from continuing operations before tax | | | | | | | | | 179 | | | | | 185 | | | | | 154 | | | | | 1,179 | | | | | 129 | | | | | 716 | | | | | 215 | | | | | 119 | | | | |
Certain Items attributable to Celanese Corporation (Table 8) | | | | | | | | | 114 | | | | | 102 | | | | | 97 | | | | | (114) | | | | | 139 | | | | | (438) | | | | | 54 | | | | | 131 | | | | |
| Refinancing and related expenses | | | | | | | — | | | | — | | | | — | | | | 7 | | | | — | | | | 7 | | | | — | | | | — | | | |
| Adjusted earnings (loss) from continuing operations before tax | | | | | | | | | 293 | | | | | 287 | | | | | 251 | | | | | 1,072 | | | | | 268 | | | | | 285 | | | | | 269 | | | | | 250 | | | | |
Income tax (provision) benefit on adjusted earnings(1) | | | | | | | | | (26) | | | | | (26) | | | | | (23) | | | | | (96) | | | | | (23) | | | | | (11) | | | | | (32) | | | | | (30) | | | | |
Adjusted earnings (loss) from continuing operations(2) | | | | | | | | | 267 | | | 2.44 | | | 261 | | | 2.38 | | | 228 | | | 2.08 | | | 976 | | | 8.92 | | | 245 | | | 2.24 | | | 274 | | | 2.50 | | | 237 | | | 2.17 | | | 220 | | | 2.01 | | |
| | | | | | | | | Diluted shares (in millions)(3) | |
| Weighted average shares outstanding | | | | | | | | | 109.3 | | | | | 109.3 | | | | | 109.1 | | | | | 108.8 | | | | | 109.0 | | | | | 108.9 | | | | | 108.9 | | | | | 108.6 | | | | |
| Incremental shares attributable to equity awards | | | | | | | | | 0.2 | | | | | 0.2 | | | | | 0.4 | | | | | 0.6 | | | | | 0.5 | | | | | 0.5 | | | | | 0.4 | | | | | 0.6 | | | | |
| Total diluted shares | | | | | | | | | 109.5 | | | | | 109.5 | | | | | 109.5 | | | | | 109.4 | | | | | 109.5 | | | | | 109.4 | | | | | 109.3 | | | | | 109.2 | | | | |
______________________________(1)Calculated using adjusted effective tax rates (Table 3a) as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 |
| | | | | | | | | |
| Adjusted effective tax rate | | | | | | | | | 9 | | | | | 9 | | | | | 9 | | | | | 9 | | | | | 9 | | | | | 4 | | | | | 12 | | | | | 12 | | | |
(2)Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns.
| | | | | | | | | | | | | | | | |
| | | | Actual Plan Asset Returns | | Expected Plan Asset Returns |
| | | | (In percentages) |
| | | | | | |
| 2023 | | | | 8.1 | | | 5.2 | |
(3)Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.
Table 3a
Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited
| | | | | | | | | | | | | | |
| Estimated | | Actual | |
| 2024 | | 2023 | |
| (In percentages) | |
| US GAAP annual effective tax rate | 26 | | | (67) | | |
Discrete quarterly recognition of GAAP items(1) | (5) | | | 2 | | |
Tax impact of other charges and adjustments(2) | (1) | | | (3) | | |
| | | | |
| | | | |
Changes in valuation allowances, excluding impact of other charges and adjustments(3) | (8) | | | 13 | | |
Other, includes effect of discrete current year transactions(4) | (3) | | | 64 | | (5) |
| Adjusted tax rate | 9 | | | 9 | | |
______________________________
Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate for actual results.
(1)Such as changes in tax laws (including US tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments.
(2)Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes. (3)Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments.
(4)Includes tax impacts related to full-year actual tax opportunities and related costs, as well as current year realization of U.S. GAAP benefits deferred in prior years.
(5)Includes the reversal of certain U.S. GAAP deferred tax benefits related to non-recurring internal restructuring transactions related to the M&M acquisition, to centralize ownership of intellectual property with the business and to facilitate future deployment of cash to service acquisition indebtedness. Certain benefits of the internal restructuring will be realized in future periods for adjusted earnings purposes.
Table 4
Net Sales by Segment - Unaudited
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 |
| | | | | (In $ millions) |
| Engineered Materials | | | | | 1,481 | | | 1,467 | | | 1,378 | | | 6,149 | | | 1,406 | | | 1,528 | | | 1,585 | | | 1,630 | |
| | | | | | | | | | | | | | | | | | | |
| Acetyl Chain | | | | | 1,190 | | | 1,202 | | | 1,261 | | | 4,884 | | | 1,181 | | | 1,220 | | | 1,233 | | | 1,250 | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Intersegment eliminations(1) | | | | | (23) | | | (18) | | | (28) | | | (93) | | | (18) | | | (25) | | | (23) | | | (27) | |
| Net sales | | | | | 2,648 | | | 2,651 | | | 2,611 | | | 10,940 | | | 2,569 | | | 2,723 | | | 2,795 | | | 2,853 | |
___________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
Table 4a
Factors Affecting Segment Net Sales Sequentially - Unaudited
Three Months Ended September 30, 2024 Compared to Three Months Ended June 30, 2024
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| | (In percentages) | |
| Engineered Materials | — | | | — | | | 1 | | | | | 1 | | |
| | | | | | | | | | |
| Acetyl Chain | — | | | (2) | | | 1 | | | | | (1) | |
|
| | | | | | | | | | |
| Total Company | — | | | (1) | | | 1 | | | | | — | | |
Three Months Ended June 30, 2024 Compared to Three Months Ended March 31, 2024
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| (In percentages) | |
| Engineered Materials | 7 | | | — | | | (1) | | | | | 6 | | |
| | | | | | | | | | |
| Acetyl Chain | (1) | | | (4) | | | — | | | | | (5) | |
|
| | | | | | | | | | |
| Total Company | 4 | | | (2) | | | — | | | | | 2 | | |
Three Months Ended March 31, 2024 Compared to Three Months Ended December 31, 2023
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| (In percentages) | |
| Engineered Materials | (1) | | | (1) | | | — | | | | | (2) | | |
| | | | | | | | | | |
| Acetyl Chain | 5 | | | 1 | | | 1 | | | | | 7 | |
|
| | | | | | | | | | |
| Total Company | 2 | | | — | | | — | | | | | 2 | | |
Three Months Ended December 31, 2023 Compared to Three Months Ended September 30, 2023
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| (In percentages) | |
| Engineered Materials | (5) | | | (3) | | | — | | | | | (8) | | (1) |
| | | | | | | | | | |
| Acetyl Chain | — | | | (3) | | | — | | | | | (3) | |
|
| | | | | | | | | | |
| Total Company | (3) | | | (3) | | | — | | | | | (6) | | |
________________________(1)Includes the effect of the formation of the Nutrinova joint venture.
Three Months Ended September 30, 2023 Compared to Three Months Ended June 30, 2023
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| (In percentages) | |
| Engineered Materials | (1) | | | (3) | | | — | | | | | (4) | | |
| | | | | | | | | | |
| Acetyl Chain | 3 | | | (3) | | | (1) | | | | | (1) | |
|
| | | | | | | | | | |
| Total Company | 1 | | | (3) | | | (1) | | | | | (3) | | |
Three Months Ended June 30, 2023 Compared to Three Months Ended March 31, 2023
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| (In percentages) | |
| Engineered Materials | 2 | | | (5) | | | — | | | | | (3) | | |
| | | | | | | | | | |
| Acetyl Chain | 2 | | | (3) | | | — | | | | | (1) | |
|
| | | | | | | | | | |
| Total Company | 2 | | | (4) | | | — | | | | | (2) | | |
Three Months Ended March 31, 2023 Compared to Three Months Ended December 31, 2022
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| (In percentages) | |
| Engineered Materials | 34 | | | (4) | | | 2 | | | | | 32 | | |
| | | | | | | | | | |
| Acetyl Chain | 10 | | | (2) | | | 2 | | | | | 10 | |
|
| | | | | | | | | | |
| Total Company | 19 | | | (4) | | | 2 | | | | | 17 | | |
Table 4b
Factors Affecting Segment Net Sales Year Over Year - Unaudited
Three Months Ended September 30, 2024 Compared to Three Months Ended September 30, 2023
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| | (In percentages) | |
| Engineered Materials | (1) | | | (2) | | | — | | | | | (3) | | |
| | | | | | | | | | |
| Acetyl Chain | 1 | | | (3) | | | — | | | | | (2) | | |
| | | | | | | | | | |
| Total Company | — | | | (3) | | | — | | | | | (3) | | |
Three Months Ended June 30, 2024 Compared to Three Months Ended June 30, 2023
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| (In percentages) | |
| Engineered Materials | (2) | | | (4) | | | (1) | | | | | (7) | | |
| | | | | | | | | | |
| Acetyl Chain | 4 | | | (6) | | | (1) | | | | | (3) | | |
| | | | | | | | | | |
| Total Company | 1 | | | (5) | | | (1) | | | | | (5) | | |
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| (In percentages) | |
| Engineered Materials | (12) | | | (2) | | | (1) | | | | | (15) | | |
| | | | | | | | | | |
| Acetyl Chain | 11 | | | (10) | | | — | | | | | 1 | | |
| | | | | | | | | | |
| Total Company | (2) | | | (5) | | | (1) | | | | | (8) | | |
Three Months Ended December 31, 2023 Compared to Three Months Ended December 31, 2022
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| (In percentages) | |
| Engineered Materials | 21 | | | (8) | | | 1 | | | | | 14 | | |
| | | | | | | | | | |
| Acetyl Chain | 14 | | | (11) | | | 1 | | | | | 4 | | |
| | | | | | | | | | |
| Total Company | 18 | | | (10) | | | 1 | | | | | 9 | | |
Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| | (In percentages) | |
| Engineered Materials | 75 | | | (12) | | | 1 | | | | | 64 | | |
| | | | | | | | | | |
| Acetyl Chain | 4 | | | (18) | | | 1 | | | | | (13) | | |
| | | | | | | | | | |
| Total Company | 33 | | | (16) | | | 1 | | | | | 18 | | |
Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| | (In percentages) | |
| Engineered Materials | 75 | | | (8) | | | — | | | | | 67 | | |
| | | | | | | | | | |
| Acetyl Chain | (2) | | | (19) | | | — | | | | | (21) | | |
| | | | | | | | | | |
| Total Company | 27 | | | (15) | | | — | | | | | 12 | | |
Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| | (In percentages) | |
| Engineered Materials | 80 | | | 2 | | | (3) | | | | | 79 | | |
| | | | | | | | | | |
| Acetyl Chain | (9) | | | (13) | | | (2) | | | | | (24) | | |
| | | | | | | | | | |
| Total Company | 23 | | | (8) | | | (3) | | | | | 12 | | |
Table 4c
Factors Affecting Segment Net Sales Year Over Year - Unaudited
Year Ended December 31, 2023 Compared to Year Ended December 31, 2022
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Volume | | Price | | Currency | | | | Total | |
| | (In percentages) | |
| Engineered Materials | 54 | | | (1) | | | — | | | | | 53 | | |
| | | | | | | | | | |
| Acetyl Chain | 2 | | | (17) | | | — | | | | | (15) | | |
| | | | | | | | | | |
| Total Company | 23 | | | (10) | | | — | | | | | 13 | | |
Table 5
Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 |
| | | | | (In $ millions, except percentages) |
| Net cash provided by (used in) investing activities | | | | | (100) | | | (91) | | | (151) | | | (134) | | | (168) | | | 375 | | | (163) | | | (178) | |
| Net cash provided by (used in) financing activities | | | | | (376) | | | (489) | | | (259) | | | (1,456) | | | (240) | | | (700) | | | (447) | | | (69) | |
| | | | | | | | | | | | | | | | | | | |
| Net cash provided by (used in) operating activities | | | | | 79 | | | 292 | | | 101 | | | 1,899 | | | 830 | | | 403 | | | 762 | | | (96) | |
| Capital expenditures on property, plant and equipment | | | | | (88) | | | (105) | | | (137) | | | (568) | | | (128) | | | (131) | | | (145) | | | (164) | |
| Contributions from/(Distributions) to NCI | | | | | (7) | | | (14) | | | (4) | | | (11) | | | — | | | (4) | | | (6) | | | (1) | |
Free cash flow(1) | | | | | (16) | | | 173 | | | (40) | | | 1,320 | | | 702 | | | 268 | | | 611 | | | (261) | |
| | | | | | | | | | | | | | | | | | | |
| Net sales | | | | | 2,648 | | | 2,651 | | | 2,611 | | | 10,940 | | | 2,569 | | | 2,723 | | | 2,795 | | | 2,853 | |
| | | | | | | | | | | | | | | | | | | |
| Free cash flow as % of Net sales | | | | | (0.6) | % | | 6.5 | % | | (1.5) | % | | 12.1 | % | | 27.3 | % | | 9.8 | % | | 21.9 | % | | (9.1) | % |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
______________________________
(1)Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures.
Table 6
Cash Dividends Received - Unaudited
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 |
| | | | | (In $ millions) |
| Dividends from equity method investments | | | | | 26 | | | 69 | | | 27 | | | 157 | | | 85 | | | 7 | | | 25 | | | 40 | |
| Dividends from equity investments without readily determinable fair values | | | | | 30 | | | 31 | | | 34 | | | 126 | | | 31 | | | 30 | | | 31 | | | 34 | |
| Total | | | | | 56 | | | 100 | | | 61 | | | 283 | | | 116 | | | 37 | | | 56 | | | 74 | |
Table 7
Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 |
| | | | | (In $ millions) |
| Short-term borrowings and current installments of long-term debt - third party and affiliates | | | | | 1,607 | | | 1,977 | | | 2,439 | | | 1,383 | | | 1,383 | | | 1,408 | | | 1,507 | | | 1,386 | |
| Long-term debt, net of unamortized deferred financing costs | | | | | 11,324 | | | 11,058 | | | 11,018 | | | 12,301 | | | 12,301 | | | 12,291 | | | 12,889 | | | 13,396 | |
| Total debt | | | | | 12,931 | | | 13,035 | | | 13,457 | | | 13,684 | | | 13,684 | | | 13,699 | | | 14,396 | | | 14,782 | |
| Cash and cash equivalents | | | | | (813) | | | (1,185) | | | (1,483) | | | (1,805) | | | (1,805) | | | (1,357) | | | (1,296) | | | (1,167) | |
| Net debt | | | | | 12,118 | | | 11,850 | | | 11,974 | | | 11,879 | | | 11,879 | | | 12,342 | | | 13,100 | | | 13,615 | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Table 8
Certain Items - Unaudited
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Q3 '24 | | Q2 '24 | | Q1 '24 | | 2023 | | Q4 '23 | | Q3 '23 | | Q2 '23 | | Q1 '23 | | Income Statement Classification |
| | | | | (In $ millions) | | |
| Exit and shutdown costs | | | | | 52 | | | 69 | | | 68 | | | 89 | | | 33 | | | 9 | | | 21 | | | 26 | | | Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Non-operating pension and other postretirement employee benefit (expense) income |
| Asset impairments | | | | | 34 | | (1) | 3 | | | — | | | 15 | | | 6 | | | 9 | | | — | | | — | | | Cost of sales / Other (charges) gains, net |
| Impact from plant incidents and natural disasters | | | | | 3 | | (2) | — | | | 7 | | (3) | 6 | | | — | | | — | | | — | | | 6 | | (4) | Cost of sales |
| Mergers, acquisitions and dispositions | | | | | 17 | | | 26 | | | 25 | | | 195 | | | 27 | | | 46 | | | 23 | | | 99 | | | Cost of sales / SG&A |
| Actuarial (gain) loss on pension and postretirement plans | | | | | — | | | — | | | — | | | 69 | | | 69 | | | — | | | — | | | — | | | Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income |
| Legal settlements and commercial disputes | | | | | 7 | | | 3 | | | (8) | | | 12 | | | 4 | | | 2 | | | 6 | | | — | | | Cost of sales / SG&A / Other (charges) gains, net |
| | | | | | | | | | | | | | | | | | | | | |
| (Gain) loss on disposition of businesses and assets | | | | | 1 | | | 1 | | | — | | | (510) | | | (3) | | | (508) | | | 1 | | | — | | | Gain (loss) on disposition of businesses and assets, net |
| Other | | | | | — | | | — | | | 5 | | | 10 | | | 3 | | | 4 | | | 3 | | | — | | | Cost of sales / SG&A |
| Certain Items attributable to Celanese Corporation | | | | | 114 | | | 102 | | | 97 | | | (114) | | | 139 | | | (438) | | | 54 | | | 131 | | | |
___________________________
(1)Related to impairment of certain tradenames, primarily Zytel®, in connection with our annual goodwill and indefinite-lived intangible asset impairment tests.
(2)Primarily associated with Hurricane Beryl and Hurricane Helene.
(3)Primarily associated with Winter Storm Heather.
(4)Primarily associated with Winter Storm Elliott.
Table 9
Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | 2023 |
| | | | | | | | | | | (In $ millions, except percentages) |
| Net earnings (loss) attributable to Celanese Corporation | | | | | | | | | | | 1,960 | |
| | | | | | | | | | | |
| | | | | | | | | | | 1,753 | |
| | | | | | | | | | | 9 | % |
| Adjusted EBIT tax effected | | | | | | | | | | | 1,595 | |
| | | | | | | | | | | |
| | | | | | | 2023 | | 2022 | | Average |
| | | | | | | (In $ millions, except percentages) |
| Short-term borrowings and current installments of long-term debt - third parties and affiliates | | | | | | | 1,383 | | | 1,306 | | | 1,345 | |
| Long-term debt, net of unamortized deferred financing costs | | | | | | | 12,301 | | | 13,373 | | | 12,837 | |
| Celanese Corporation shareholders' equity | | | | | | | 7,091 | | | 5,637 | | | 6,364 | |
| Invested capital | | | | | | | | | | | 20,546 | |
| | | | | | | | | | | |
| Return on invested capital (adjusted) | | | | | | | | | | | 7.8 | % |
| | | | | | | | | | | |
| Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital | | | | | | | | | | | 9.5 | % |
Document and Entity Information Document
|
Nov. 04, 2024 |
| Entity Information [Line Items] |
|
| Entity Information, Former Legal or Registered Name |
N/A
|
| Document Type |
8-K
|
| Document Period End Date |
Nov. 04, 2024
|
| Entity Registrant Name |
CELANESE CORPORATION
|
| Entity Incorporation, State or Country Code |
DE
|
| Entity File Number |
001-32410
|
| Entity Tax Identification Number |
98-0420726
|
| Entity Address, Address Line One |
222 West Las Colinas Blvd. Suite 900N
|
| Entity Address, City or Town |
Irving
|
| Entity Address, State or Province |
TX
|
| Entity Address, Postal Zip Code |
75039
|
| City Area Code |
972
|
| Local Phone Number |
443-4000
|
| Written Communications |
false
|
| Soliciting Material |
false
|
| Pre-commencement Tender Offer |
false
|
| Pre-commencement Issuer Tender Offer |
false
|
| Entity Emerging Growth Company |
false
|
| Entity Central Index Key |
0001306830
|
| Amendment Flag |
false
|
| Common Stock, par value $0.0001 per share |
|
| Entity Information [Line Items] |
|
| Title of 12(b) Security |
Common Stock, par value $0.0001 per share
|
| Trading Symbol |
CE
|
| Security Exchange Name |
NYSE
|
| 1.250% Senior Notes due 2025 |
|
| Entity Information [Line Items] |
|
| Title of 12(b) Security |
1.250% Senior Notes due 2025
|
| Trading Symbol |
CE /25
|
| Security Exchange Name |
NYSE
|
| 4.777% Senior Notes due 2026 |
|
| Entity Information [Line Items] |
|
| Title of 12(b) Security |
4.777% Senior Notes due 2026
|
| Trading Symbol |
CE /26A
|
| Security Exchange Name |
NYSE
|
| 2.125% Senior Notes due 2027 |
|
| Entity Information [Line Items] |
|
| Title of 12(b) Security |
2.125% Senior Notes due 2027
|
| Trading Symbol |
CE /27
|
| Security Exchange Name |
NYSE
|
| 0.625% Senior Notes due 2028 |
|
| Entity Information [Line Items] |
|
| Title of 12(b) Security |
0.625% Senior Notes due 2028
|
| Trading Symbol |
CE /28
|
| Security Exchange Name |
NYSE
|
| 5.337% Senior Notes due 2029 |
|
| Entity Information [Line Items] |
|
| Title of 12(b) Security |
5.337% Senior Notes due 2029
|
| Trading Symbol |
CE /29A
|
| Security Exchange Name |
NYSE
|
| X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
| Name: |
dei_AmendmentFlag |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
| Name: |
dei_DocumentPeriodEndDate |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:dateItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
| Name: |
dei_DocumentType |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:submissionTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
| Name: |
dei_EntityAddressAddressLine1 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
+ References
+ Details
| Name: |
dei_EntityAddressCityOrTown |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCode for the postal or zip code
| Name: |
dei_EntityAddressPostalZipCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the state or province.
| Name: |
dei_EntityAddressStateOrProvince |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:stateOrProvinceItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityCentralIndexKey |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:centralIndexKeyItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionIndicate if registrant meets the emerging growth company criteria. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityEmergingGrowthCompany |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
| Name: |
dei_EntityFileNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:fileNumberItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
| Name: |
dei_EntityIncorporationStateCountryCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarStateCountryItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityRegistrantName |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityTaxIdentificationNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:employerIdItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionLocal phone number for entity.
| Name: |
dei_LocalPhoneNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
| Name: |
dei_PreCommencementIssuerTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
| Name: |
dei_PreCommencementTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTitle of a 12(b) registered security. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
| Name: |
dei_Security12bTitle |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:securityTitleItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the Exchange on which a security is registered. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
| Name: |
dei_SecurityExchangeName |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarExchangeCodeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
| Name: |
dei_SolicitingMaterial |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
| Name: |
dei_TradingSymbol |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:tradingSymbolItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
| Name: |
dei_WrittenCommunications |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=ce_EURSeniorUnsecuredNotesDue2025Member |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=ce_EURSeniorUnsecuredNotesDue2026Member |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=ce_EURSeniorUnsecuredNotesDue2027Member |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=ce_EURSeniorUnsecuredNotesDue2028Member |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=ce_EURSeniorUnsecuredNotesDue2029Member |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
Celanese (NYSE:CE)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Celanese (NYSE:CE)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
